$POWL

Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks

Powell Industries reported Q3 EPS of $1.42, below the $1.47 analyst consensus, and sales of $312.0 million, below the $315.168 million estimate, according to the company. Shares fell 13.4% to $190.02 in pre-market trading. The article also notes Nasdaq 100 futures were up about 150 points.

Original reporting
Published Aug 4, 2026, 12:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 1:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$POWL
Bearish
medium confidence
Mentioned
$POWL · $CLPT
Relevance
7/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$POWLBearishMed
01

Why it matters

The disclosed EPS and revenue misses, paired with a 13.4% premarket decline, are the actionable elements for traders assessing near-term estimate risk.

02

Market read

Traders can use the consensus miss and magnitude of the premarket move to gauge immediate sentiment and potential estimate revisions.

03

What to watch

The article does not include management guidance, margin details, or segment performance, which could materially change the earnings interpretation.

Relevance 7/10Novelty 6/10Timing: pre-market today after Q3 results

Background

The piece is a premarket earnings snapshot for Powell Industries, comparing reported Q3 figures to analyst consensus.

Company-level read

Ticker impact

$POWLBearishMedium confidence
Context

Powell Industries reported Q3 EPS of $1.42 vs $1.47 consensus and sales of $312.0M vs $315.168M, with shares down 13.4% premarket.

Expected impact

Bearish bias for the next session(s) as traders reprice the earnings miss versus consensus.

Evidence & confidence

The article provides the miss versus consensus and a large premarket decline, indicating the market is reacting to the disclosed results.

Market effects

Weak results in an industrial/auto-supply name can pressure sentiment for similarly exposed industrial suppliers, though no sector-wide catalyst is provided.

No specific regional spillover is described beyond broad futures being higher.

No global macro or international demand signal is included.

Counterpoint

The stock may be overreacting to a modest EPS and sales miss if margins, backlog, or guidance (not provided here) were resilient.

Key entities

  • Powell Industries

    Reported Q3 EPS and sales that missed consensus, and the stock fell sharply in premarket trading.

Related articles

$CLPTHighAI 8/10

ClearPoint Neuro stock tumbles on uniQure trial setback

ClearPoint Neuro (CLPT) shares dropped 24% after partner uniQure (QURE) reported disappointing trial data for its Huntington's disease treatment, AMT-130. The therapy failed to meet primary clinical measures, raising concerns about future revenue for ClearPoint Neuro, which provides delivery hardware and software for the treatment.

$POWLMed

Powell Industries Eyes Record Revenue as Data Center Backlog Powers Growth

Powell Industries (POWL) reports strong data center demand, with backlog extending into 2028. The company expects significant growth for 3-5 years, driven by high-voltage systems and new customer segments. Powell differentiates itself with integrated solutions and automation. It has $600M cash, no debt, and plans capacity expansions. Management sees potential in service revenue from its installed base.

$POWLMedAI 9/10

Powell Industries (POWL) Q3 2026 Earnings Call Transcript

Powell Industries (POWL) reported Q3 FY2026 revenue of $312 million, up 9% year over year, and diluted EPS of $1.42, up 8%. New orders rose to $934 million, up 158%, lifting backlog to a record $2.4 billion. Management cited data center demand over $400 million and a debt-free balance sheet with $634 million liquidity.